Fund moves
128KShares reported
6 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jan 24, 2025 · Filed Jan 27, 2025
Madrigal Pharmaceuticals's Senior VP, Chief Pharma Dev. sold $35K of Madrigal Pharmaceuticals shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$34,530
Shares × reported transaction price
11 days after results of Jan 13, 2025, 33 days before results of Feb 26, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Fund moves
6 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Fund moves
6 tracked managers disclosed the same change for Q4 2024. Among this manager's largest new positions for Q4 2024.
Fund moves
6 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 10, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.